Question explored with the scientific record
Treatment for ear crystals
The short version: for ear crystals, the repositioning maneuvers are the one treatment with real sham-controlled evidence, and they work.
"Ear crystals" is benign paroxysmal positional vertigo, or BPPV: loose calcium crystals in the inner ear that trigger brief spinning when you move your head. The treatment is a physical repositioning maneuver, usually the Epley or canalith repositioning procedure, where a clinician turns your head through a set sequence to guide the crystals back where they belong. This is not a drug, so the usual pharma conflict does not apply. The evidence is genuinely good: a review of 292 patients found the maneuver resolved symptoms far more often than a fake maneuver, with success rates of 32% to 80% versus 10% to 34% for sham [1]. Individual trials back this up, with 61% versus 20% complete resolution in one study and 80% versus 10% symptom-free at 24 hours in another [2].
| Comparison | Maneuver | Sham/fake |
|---|---|---|
| Symptom resolution (pooled) | 32–80% | 10–34% [1] |
| Complete resolution, 36 patients | 61% | 20% [2] |
| Asymptomatic at 24 hours, 66 patients | 80% | 10% [2] |
| Symptom-free vs no treatment, 29 patients | 41% | 3% [2] |
Adding mastoid vibration to the maneuver did not improve results (84% vs 73%, not significant) [3]. A 10-year series of 592 patients found most got immediate relief, with recurrence risk around 18% by 10 years [5]. One small study found vestibular suppressant drugs reduced leftover lightheadedness after a successful maneuver [6], but that treats residual symptoms, not the crystals themselves. Recurrence is real: one study found about 19% recurred within 6 months [4].
My call: get the maneuver from someone trained to do it, expect it to work, and expect it may need repeating. Confidence: high for the maneuver's short-term benefit; moderate on long-term recurrence.
Sources used 6
-
Effectiveness of the Canalith Repositioning Procedure in the Treatment of Benign Paroxysmal Positional Vertigo
This study evaluates the effectiveness of the canalith repositioning procedure (CRP) for treating benign paroxysmal positional vertigo (BPPV) and compares its outcomes to sham treatments and controls, demonstrating significant improvements in symptom resolution and conversion fr…
DOI: 10.2522/ptj.20130239 -
Practice Parameter: Therapies for benign paroxysmal positional vertigo (an evidence-based review): [RETIRED]
This evidence-based review evaluates various therapies for benign paroxysmal positional vertigo (BPPV), focusing on the efficacy of repositioning maneuvers and other treatment options.
DOI: 10.1212/01.wnl.0000313378.77444.ac -
Mastoid Oscillation in Canalith Repositioning for Paroxysmal Positional Vertigo
This study investigates the efficacy of mastoid oscillation in enhancing the canalith repositioning procedure for treating paroxysmal positional vertigo, finding no significant improvement in outcomes with the addition of oscillation.
DOI: 10.1097/00129492-200103000-00015 -
Role of Vestibular Evoked Myogenic Potentials as an Indicator of Recovery in Patients with Benign Paroxysmal Positional Vertigo
A prospective study of 48 patients with unilateral posterior canal BPPV showing that vestibular evoked myogenic potentials, especially the oVEMP amplitude ratio, change after successful Epley maneuvers and can predict recurrence, supporting otoconia return to the utricle as part…
DOI: 10.20471/acc.2017.56.04.25 -
Benign Paroxysmal Positional Vertigo: 10‐Year Experience in Treating 592 Patients with Canalith Repositioning Procedure
This study evaluates the long-term efficacy of the canalith repositioning procedure (CRP) in treating benign paroxysmal positional vertigo (BPPV) in 592 patients over a 10-year period, demonstrating a high success rate and low recurrence of symptoms.
DOI: 10.1097/01.mlg.0000175062.36144.b9 -
Vestibular suppressants after canalith repositioning in benign paroxysmal positional vertigo
This study investigates the effects of vestibular suppressants on residual symptoms after successful canalith repositioning procedures in patients with benign paroxysmal positional vertigo, finding that such medications significantly reduce these symptoms compared to placebo and…
DOI: 10.1002/lary.24741